Live Breaking News & Updates on Interline Therapeutics
Stay updated with breaking news from Interline therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Jim Tananbaum, Founder and CEO of Foresite Capital, Announces $173 Million in Funds Raised for Foresite Labs Incubated Companies lapostexaminer.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lapostexaminer.com Daily Mail and Mail on Sunday newspapers.
Follow the Money: Single-Cell Analysis, Spatial Biology, Drug-Resistant Infection Treatments, 3D Genomics bio-itworld.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bio-itworld.com Daily Mail and Mail on Sunday newspapers.
Vikram (Vik) Bajaj, CEO and co-founder of Foresite Labs, recently discussed Foresite Labs and its approach to incubating data-driven drug developers, platform companies, and healthcare startups with GEN Edge: ....
Published: May 14, 2021 By Brandon May Foresite Labs-incubated company Interline Therapeutics announced Thursday that it had raised $92 million in a financing round co-led by Foresite Capital and ARCH Venture Partners. The funding, which has officially launched the company, will be geared toward the development of therapies that correct dysfunctional protein communities to treat various diseases. The $92 million financing round is a combination of seed and Series A funding. The newly launched company says the proceeds will be funneled to facilitate the expansion of its research platform and advance a total of six preclinical therapeutic programs. Interline Therapeutics will specifically use genomics, proteomics, structural biology, and computational chemistry to “map and modulate protein communities” to construct a precision medicine platform focused on genomics, protein communities, and modulators of these communities. These three pillars ....